Princeton Alpha Management’s Novavax NVAX Stock Holding History

Princeton Alpha Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-606	Closed	-$63K	–	902
2016 Q1	$63K	Buy	+606	New	+$65K	0.01%	698
2015 Q4	–	Sell	-6,939	Closed	-$981K	–	863
2015 Q3	$981K	Buy	+6,939	New	+$1.56M	0.2%	139
2015 Q2	–	Sell	-1,701	Closed	-$281K	–	842
2015 Q1	$281K	Buy	1,701 +806	+90%	+$131K	0.06%	484
2014 Q4	$106K	Buy	+895	New	+$93.5K	0.03%	631

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Princeton Alpha Management's NVAX Position: Q2 2016 in Review

Princeton Alpha Management sold out of Novavax (NVAX) in Q2 2016, closing a stake of 606 shares — an estimated $63K sold.

Princeton Alpha Management first reported a position in NVAX in Q4 2014 and held it in 4 quarters. The position peaked at $981K in Q3 2015. 186 funds tracked by Wall St. Rank hold NVAX as of Q2 2016.

Princeton Alpha Management reported no remaining Novavax position as of Q2 2016 after selling out during the quarter.
Princeton Alpha Management sold 606 Novavax shares in Q2 2016, an estimated $63K.
Princeton Alpha Management first reported a position in Novavax in Q4 2014 and held it in 4 quarters.
Princeton Alpha Management's Novavax position peaked at $981K in Q3 2015.
186 funds tracked by Wall St. Rank held Novavax as of Q2 2016.

Based on Princeton Alpha Management's 13F filing for Q2 2016, filed 5 Aug 2016.